findmyKOL

Cristina Arriens, MD

Enriched profile

Clinical Associate Professor, Arthritis & Clinical Immunology Research Program · Oklahoma Medical Research Foundation

ORCIDNPI
Region🇺🇸 Oklahoma City, OK · South Central · United StatesSpecialtyRheumatologyFocusLupus (SLE)
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Cristina Arriens is Clinical Associate Professor, Arthritis & Clinical Immunology Research Program at Oklahoma Medical Research Foundation. OpenAlex indexes 79 publications with 1,839 citations (h-index 20); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Cristina Arriens, MD, is Clinical Associate Professor, Arthritis & Clinical Immunology Research Program at Oklahoma Medical Research Foundation. The public record shows 79 publications with 1,839 citations (h-index 20), centered on Lupus (SLE). It also documents an investigator role on 2 registered clinical trials, industry payments reported by 12 companies.

  • Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
  • Top research focus: Lupus (SLE)
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 12 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lupus (SLE)2 trialsST Elevation Myocardial Infarction2 trialsErythema2 trials

Research focus

OpenAlex concept fingerprint
Lupus (SLE)

Drugs & molecules

across trials, industry payments and publications
Lupkynisgeneric · VoclosporinClinical trialsIndustry payments23Publications2Saphnelogeneric · AnifrolumabClinical trialsIndustry payments35PublicationsRinvoqgeneric · UpadacitinibClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trialsIndustry payments29Aurinia Pharma U.S., Inc.Clinical trialsIndustry payments23E.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments17

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
79publications

Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.

1,839citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
12companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Antiparasitic

    35.5%
    Antimalarial35.5%
    Hydroxychloroquine Sulfate100%
    Part D32 patients
  • Cancer & immunology

    31.8%
    Folate Analog Metabolic Inhibitor11.4%
    Methotrexate100%
    Part D<11 patients
    B Lymphocyte Stimulator-specific Inhibitor8%
    Benlysta100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    21.2%
    Corticosteroid21.2%
    Prednisone100%
    Part D22 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/cristina-arriens-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/cristina-arriens-59a0a1a3

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Cristina-Arriens-2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • X / Twitter

    X (Twitter): @CGArriens

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    The University of Texas Southwestern Medical Center, Dallas, TX

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org
  • MSCS (Master of Science in Clinical Science)

    The University of Texas Southwestern Medical Center, Dallas, TX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org
  • Internal Medicine Residency

    University of New Mexico, Albuquerque, NM

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org
  • Rheumatology Fellowship

    The University of Texas Southwestern Medical Center, Dallas, TX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →omrf.org
  • Board Certified

    American Board of Internal Medicine - Rheumatology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.ssmhealth.com

Editorial & leadership roles

journal and society appointments

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.